🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ross D. Merkin

Massachusetts Eye and Ear Infirmary

ORCID: 0000-0003-3418-2220

Also affiliated with Harvard University, Massachusetts General Hospital, MaineGeneral Medical Center, Global Cancer Institute, Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Impact of tertiary lymphoid structures in response to immune checkpoint blockade in patients with head and neck squamous cell carcinoma.”.

Impact of tertiary lymphoid structures in response to immune checkpoint blockade in patients with head and neck squamous cell carcinoma.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.e18021
N/A
0.104DataRank · unranked
1 citations

Shun Hirayama, Ross D. Merkin, Thomas J. Roberts, Manisha J. Patel, Jong C. Park +6 more

ScRNA-seq defines dynamic T-cell subsets in longitudinal colon and peripheral blood samples in immune checkpoint inhibitor-induced colitis

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007358
N/A
0DataRank · unranked
11 citations

Liliana E. Lucca, Matthew R Austin, Ross D. Merkin, Marie E. Robert, Badr Al‐Bawardy +8 more

Peripheral blood immune cell and cytokine profiling of patients receiving corticosteroids for immune checkpoint inhibitor-related adverse events: Steroid dose and duration.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e14694
N/A
0DataRank · unranked
2 citations

David A. Schoenfeld, Dijana Djureinovic, Matthew Austin, Mamie Wang, Rihao Qu +8 more

Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance

Frontiers in Oncology(2022)10.3389/fonc.2022.990367
N/A
0DataRank · unranked
20 citations

Ross D. Merkin, Myrto Moutafi, Sandra Martinez, Adebowale Adeniran, Deepika Kumar +5 more

Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer

npj Precision Oncology(2025)10.1038/s41698-025-01084-4
N/A
0DataRank · unranked
8 citations

Ross D. Merkin, Michael Bryan, Julia Mendel, Vasileios Efthymiou, Thomas J. Roberts +11 more

Clinical validation of an HPV whole genome sequencing assay for molecular residual disease detection in HPV-associated head and neck cancer patients treated with surgery

medRxiv(2025)10.1101/2025.11.24.25340887
N/A
0DataRank · unranked
0 citations

Yana Al-Inaya, Michael Bryan, Dipon Das, Ling Aye, Saskia Naegele +19 more

Immune Cell Densities Predict Response to Immune Checkpoint-Blockade in Head and Neck Cancer

medRxiv(2024)10.1101/2024.09.10.24313432
N/A
0DataRank · unranked
2 citations

Michael Bryan, Shun Hirayama, Ross D. Merkin, Luciani Evelyn, Thomas J. Roberts +8 more